Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

Delayed Data
As of May 26
 +0.045 / +0.53%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 17.00, with a high estimate of 17.00 and a low estimate of 17.00. The median estimate represents a +99.88% increase from the last price of 8.51.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Adamis Pharmaceuticals Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 31.82%
Growthannually 44.55%


Growthquarterly 694.47%
Growthannually -100.00%
Key to the earnings and sales forecast charts.